Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 80.24 USD 0.88% Market Closed
Market Cap: 31.3B USD
Have any thoughts about
Dexcom Inc?
Write Note

Dexcom Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dexcom Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Dexcom Inc
NASDAQ:DXCM
Revenue
$4B
CAGR 3-Years
19%
CAGR 5-Years
24%
CAGR 10-Years
33%
Becton Dickinson and Co
NYSE:BDX
Revenue
$20.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%
No Stocks Found

Dexcom Inc
Revenue Breakdown

Breakdown by Geography
Dexcom Inc

Total Revenue: 3.6B USD
100%
United States: 2.6B USD
72.5%
International: 997m USD
27.5%

Breakdown by Segments
Dexcom Inc

Not Available

Dexcom Inc
Glance View

Market Cap
31.3B USD
Industry
Health Care
Economic Moat
Narrow

Dexcom Inc. emerged as a pioneering force in the realm of continuous glucose monitoring (CGM), redefining the landscape of diabetes management. Founded in 1999, this San Diego-based company disrupted traditional blood glucose monitoring with its innovative technology, allowing individuals to track glucose levels in real-time without frequent finger-pricking. The company’s CGM systems, such as the G6 model, utilize a small sensor inserted beneath the skin that transmits data to a wearable device or smartphone, allowing patients and healthcare providers a comprehensive view of glucose trends. This approach empowers users with critical information for better diabetes management, reducing the likelihood of complications resulting from high or low blood sugar. Dexcom’s revenue generation revolves around the sales of its CGM systems, sensors, and related software services. By selling the initial monitoring devices and disposable sensors that typically need to be replaced every ten days, the company ensures a steady, recurring revenue stream. Furthermore, its integration with healthcare providers and insurers broadens its reach, tapping into a vast network of patients worldwide. Dexcom also collaborates with tech giants to enhance interoperability and data analytics, thereby embedding its solutions in broader digital health ecosystems. As diabetes continues to be a growing global concern, Dexcom’s strategic focus on innovation and strategic partnerships positions it as a leader in the CGM market.

DXCM Intrinsic Value
44.01 USD
Overvaluation 45%
Intrinsic Value
Price

See Also

What is Dexcom Inc's Revenue?
Revenue
4B USD

Based on the financial report for Sep 30, 2024, Dexcom Inc's Revenue amounts to 4B USD.

What is Dexcom Inc's Revenue growth rate?
Revenue CAGR 10Y
33%

Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Dexcom Inc have been 19% over the past three years , 24% over the past five years , and 33% over the past ten years .

Back to Top